Beyond Market Size: How Patient, Epidemiology & Competitive Intelligence Can Shape Oncology Investment Strategies
Background: A biopharmaceutical company was evaluating the investment potential of a targeted oncology asset. Initial market assessments appeared attractive. The indication had a sizable patient popu ...
Anticipating the Next Move: AI at the Core of Competitive Intelligence
Introduction: In today's competitive pharmaceutical industry, success relies on anticipating market changes. With rapidly growing data sources, AI-powered data analytics solutions, and predictive mod ...